chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Excessive diarrhea - watery. X 2/ 8-10. X 3 + 8-11. Anorexic.
exposed to COVID-19 via her boyfriend/her boyfriend had Pfizer vaccine; exposed to COVID-19 via her boyfriend/her boyfriend had Pfizer vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): US-MO-MOC20230116000216 (Moderna).  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "exposed to COVID-19 via her boyfriend/her boyfriend had Pfizer vaccine".  Clinical course: Calling to report that she had 4 Moderna COVID-19 shots. The last booster was administered on 30Sep2022, and she was exposed to COVID-19 via her boyfriend during Christmas holidays. She would like to compliment Moderna because she did not catch COVID disease after being exposed. She states that the vaccine worked pretty well. She states that her boyfriend had Pfizer vaccine.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
5OCT94 mom phoned clinic stating pt's face was swollen, feet swollen & red; pt had a rash all over body; mom also states pt was sleepy & refusing any food, fluid, & medicine;
had employee have splash of vaccine in eye; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT (had employee have splash of vaccine in eye) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT (had employee have splash of vaccine in eye). At the time of the report, ACCIDENTAL EXPOSURE TO PRODUCT (had employee have splash of vaccine in eye) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
Pt received both FLUAD and PNEUMOVAX in left arm. Patient states almost right away her arm swelled to softball size and with in 2 hours was red and hot down to the elbow. She went to primary doctor 2 days later and was given BACTRIM for cellulitis.
The day after the 2nd vaccine I was very tired. On March 1 I broke out with hives on both lower arms. Today is March 6 and I still have the hives.
felt very low on energy; sleepiness; second dose administered less than 26 days; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (felt very low on energy), SOMNOLENCE (sleepiness) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered less than 26 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (felt very low on energy), SOMNOLENCE (sleepiness) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered less than 26 days). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-103227 (Patient Link).
STIFFNESS IN ARM KIND OF HARD TO OPEN AND CLOSE THEM; BLURRY VISION THAT COMES AND GOES; PAIN THAT FEELS LIKE INFLAMMATION; JOINT PAIN THAT FEELS LIKE ARTHRITIS PAIN; SHARP PAIN IN HEAD; STRANGE BRUISES ON HANDS AND LEGS; TINNITED (RINGING IN EARS) AND HAVING DIFFICULT IN SLEEPING BECAUSE OF RINGING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included lung disease, and other pre-existing medical conditions included patient has taken anti-inflammatory medication in the past for lung disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced strange bruises on hands and legs. On APR-2021, the subject experienced tinnited (ringing in ears) and having difficult in sleeping because of ringing. On an unspecified date, the subject experienced stiffness in arm kind of hard to open and close them, blurry vision that comes and goes, pain that feels like inflammation, joint pain that feels like arthritis pain, and sharp pain in head. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tinnited (ringing in ears) and having difficult in sleeping because of ringing, and the outcome of strange bruises on hands and legs, sharp pain in head, joint pain that feels like arthritis pain, stiffness in arm kind of hard to open and close them, blurry vision that comes and goes and pain that feels like inflammation was not reported. This report was non-serious.
increased neutrophils , decreased lymphs 4/26/21    rash 1 inch from injection site  approx 6 cm raised itchy, recurrent...had 2 days after vaccine, subsided until today returned at 11 days post vaccine
2nd dose: arm hurt a little; This is a spontaneous report from a contactable consumer (patient). An 87-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) intramuscularly on 04Feb2021 at 15:10 (at the age of 87-years-old) as a single dose in the arm for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 (lot number EL8982) on 14Jan2021 at 14:50 as a single dose in the arm for COVID-19 immunization. On an unspecified date after dose 2 of BNT162B2 the patient experienced arm hurt a little. The event was reported as non-serious. The outcome of arm hurt a little was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
STARTED USING THE JANSSEN COVID-19 VACCINE AS A SECOND DOSE WHO HAD ALLERGIC REACTION UPON RECEIVING PFIZER OR MODERNA AS FIRST DOSE; This spontaneous report received from a health care professional concerned multiple patients. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergic reaction upon receiving pfizer or moderna. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included bnt 162, and mrna 1273.  On an unspecified date, the patient experienced started using the janssen covid-19 vaccine as a second dose who had allergic reaction upon receiving pfizer or moderna as first dose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of started using the janssen covid-19 vaccine as a second dose who had allergic reaction upon receiving pfizer or moderna as first dose was not reported. This report was non-serious.
OUR FACILITY HAD CONDUCTED A VACCINE CLINIC ASSOCIATED WITH A PHYSICIAN'S OFFICE ON FRIDAY APRIL 2, 2021. THERE WERE 7 DOSES THAT WERE NOT GIVEN. THEY WERE RETURNED TO THE PHARMACY AND WE WERE TRYING TO MAKE SURE AND NOT WASTE THOSE DOSES. A LOCAL BUSINESS SAID THEY WOULD SEND SOME PEOPLE DOWN TO GET VACCINATED. WE ASKED IF THEY WERE ALL 18. THEY SAID YES. WHEN THE PATIENT CAME IN, I WAS GIVING A VACCINE TO A PATIENT IN THEIR VEHICLE OUTSIDE. I TOLD HIM TO GO INTO THE PHARMACY AND I WOULD BE RIGHT WITH HIM. PATIENT WAS THEN GIVEN THE EUA MODERNA FACT SHEE FOR VACCINE RECIPIENTS AND CAREGIVERS. HE FILLED OUT THE FORM WHILE I WAS FILLING AND CHECKING PRESCRIPTION IN OUR WORKFLOW. I CHECKED THE FACT SHEET AND SAW THAT HE HAD CHECKED YES TO THE QUESTION ABOUT PREVIOUSLY TESTING POSITIVE FOR COVID-19. I COUNSELED HIM ABOUT A POSSIBLE INCREASED IMMUNE RESPONSE TO THE FIRST DOSE OF THE MODERNA VACCINE INCLUDING: CHILLS, MUSCLE ACHES, LOW-GRADE FEVER,ETC.  I DID NOT LOOK AT THE BIRTHDATE BECAUSE I HAD BEEN TOLD HE WAS 18. (THIS  IS WHERE THE ERROR OCCURRED) I PROCEEDED TO VACCINATE THE PATIENT AND ASKED HIM TO WAIT IN HIS VEHICLE OUTSIDE FOR 15 MINUTES TO MAKE SURE HE HAD NO ADVERSE REACTION TO THE VACCINE, WITH INSTRUCTIONS TO CALL US OR HONK HIS HORN IF HE HAD ANY PROBLEMS. THE PATIENT WENT OUTSIDE TO WAIT IN HIS CAR. A TECHNICIAN NOTICED WE HAD FAILED TO GIVE HIM HIS VACCINATION CARD WITH THE RETURN DATE FOR THE SECOND DOSE, SHE TOOK THE CARD TO THE PATIENT AND AS WE THEN BEGAN ENTERING DATA TO OUR COMPUTER AND THE  SYSTEM THE BIRTHDATE WAS NOTICED. THE VACCINE HAD BEEN GIVEN, IT WAS THEN END OF THE BUSINESS DAY. OUR VACCINE COORDINATER CALLED THE DEPARTMENT OF HEALTH ON MONDAY AM ASKING DIRECTION FROM THERE. WE WERE TOLD TO REPORT TO VAERS. NO ADVERSE EVENT OCCURRED. VACCINE WAS GIVEN IN ERROR. DOH AND CDC RECOMMENDATION IS TO PROCEED WITH 2ND VACCINE.
Pain moving and throbbing up and over my left shoulder and down the front of my arm so severe that I felt faint.
1 dose administered to 1 patient from vial greater then 24 hours at room temperature; Thus receiving two doses of the vaccine within a short period of time.; product administration error; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (1 dose administered to 1 patient from vial greater then 24 hours at room temperature), INCORRECT DOSE ADMINISTERED (Thus receiving two doses of the vaccine within a short period of time.) and PRODUCT ADMINISTRATION ERROR (product administration error) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jul-2021, the patient experienced PRODUCT STORAGE ERROR (1 dose administered to 1 patient from vial greater then 24 hours at room temperature), INCORRECT DOSE ADMINISTERED (Thus receiving two doses of the vaccine within a short period of time.) and PRODUCT ADMINISTRATION ERROR (product administration error). At the time of the report, PRODUCT STORAGE ERROR (1 dose administered to 1 patient from vial greater then 24 hours at room temperature), INCORRECT DOSE ADMINISTERED (Thus receiving two doses of the vaccine within a short period of time.) and PRODUCT ADMINISTRATION ERROR (product administration error) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up received contains significant information- receiving two doses of the vaccine within a short period of time.; Sender's Comments: This report refers to a case of Product storage error temperature too high, Inappropriate dose of vaccine administered and product administration error, for mRNA-1273 with no associated AEs reported.
Pt's relative (mom) complained of irritation and a knot at the site of injection which pt. says went away after a couple of days.
two weeks after my 1st done,  i was diagnosed with IPCV Idiopathic polypoidal choroidal vasculopathy. the dr said its a fluke isn't related to the vaccine but the pharmacist where i got the shot told me to report what happened for records.
Physical weakness for 10 hours Chills for 10 minutes Sweats for 10 minutes 2 or 3 times Body Aches in small of the back Ache at injection site Slight nausea for 10 minutes, 2 or 3 times Dry Mouth - feeling of dehydration (solved by drinking water) Drowsiness - required a 3 hour day-time nap.
I been having SOB lately.   I also having high heart rate. This has been happening for about a month now.  I went to the ER (Hospital).  They did blood work, CT scan of my chest, and EKG.  I also had an x-ray of my chest.  I still waiting on the result of my Echo cardio gram and stress test.  They have not diagnosed me with anything.
4 years had not elapsed between the last meningococcal vaccine with no reported adverse event; Initial information received on 21-Feb-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 12 years old female patient who reported  4 years had not elapsed between the last meningococcal vaccine with no reported adverse event after receiving MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE VLP RL1 9V (YEAST) (GARDASIL 9) for Immunisation.  On 20-Feb-2023, the patient received  0.25 mL to 2 mL dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE solution  for injection( lot number U7449AA ) and(  expiry 24-Sep-2023) via intramuscular route in the right arm for Immunization  On 20-FEB-2023 the patient had a non-serious event " 4 years had not elapsed between the last meningococcal vaccine with no reported adverse event" (product administered to patient of inappropriate age) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE ( latency : same day )   No lab data included  Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable.  At time of reporting, the outcome was Unknown for the event 4 years had not elapsed between the last meningococcal vaccine with no reported adverse event.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
arm was a little bit red; arm was sore; warm to touch; clear outline where the vaccine was at, 4 inches across, taut; swollen; This spontaneous case was reported by an other health care professional and describes the occurrence of SKIN WARM (warm to touch), INFLAMMATION (clear outline where the vaccine was at, 4 inches across, taut), SWELLING (swollen), ERYTHEMA (arm was a little bit red) and PAIN IN EXTREMITY (arm was sore) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced SKIN WARM (warm to touch), INFLAMMATION (clear outline where the vaccine was at, 4 inches across, taut) and SWELLING (swollen). On an unknown date, the patient experienced ERYTHEMA (arm was a little bit red) and PAIN IN EXTREMITY (arm was sore). At the time of the report, SKIN WARM (warm to touch), INFLAMMATION (clear outline where the vaccine was at, 4 inches across, taut), SWELLING (swollen) and ERYTHEMA (arm was a little bit red) outcome was unknown and PAIN IN EXTREMITY (arm was sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Refrigeration excursions identified/undergone several temperature excursions; No adverse event; vaccine underwent several temperature excursions and administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (vaccine underwent several temperature excursions and administered to patient) and NO ADVERSE EVENT (No adverse event) in a 5-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Aug-2022 at 5:13 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 04-Aug-2022 at 5:13 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (vaccine underwent several temperature excursions and administered to patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (vaccine underwent several temperature excursions and administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (vaccine underwent several temperature excursions and administered to patient).    No concomitant medication was provided. It was unknown if the patient ever been diagnosed with or tested positive for COVID-19. The patient was administered the vaccine in the deltoid muscle. The vaccines were stored in the Refrigerator. There were 2 unbroken cartons with 20 vials. Date vial was moved from freezer to refrigerator on 7-Sep-2022.  Vials were not visualized for Visual inspection.  It was reported that refrigeration excursions identified, state vaccine was housed in these units. There were excursions noted.   Reportedly, the nurse called for a clinic that she was assisting. The clinic had a similar issue with vaccines stored in their freezer. Vaccines stored in the refrigerator that underwent several temperature excursions going back to August 2022.  It was reported that no adverse reactions were reported to their knowledge for the patient. Treatment medication was not provided by the reporter.
Hospitalized 09/29/2021; COVID-19 positive 09/29/2021; fully vaccinated  Assessment/Plan    DIAGNOSIS at time of disposition: 1. COVID-19  2. Acute cystitis without hematuria      New Prescriptions   No new medications prescribed this visit.     ED Disposition    ED Disposition   Hospitalized     MEDICAL DECISION MAKING Supervising Physician:  Upon arrival to the emergency department patient's vital signs are notable for hypotension.  Possible etiologies of their symptoms include sepsis, urinary tract infection, COVID-19.  Our workup in the emergency department includes urinalysis, COVID-19 test, complete blood count, CMP, magnesium, chest x-ray, lactic acid, blood cultures.  Workup was notable for urinalysis which demonstrates a urinary tract infection, positive COVID-19 test, increase lactic acid to 2.3, and a low magnesium level. Given these findings most likely etiology of their symptoms is combination of a urinary tract infection as well as COVID-19.  The patient was ambulated in the emergency department.  She was unable to walk.  She normally walks with a walker.  I spoke with her son who agrees that she should be admitted to the hospital given that her constellation of symptoms.  I spoke with the hospitalist who kindly agreed to accept the patient.  Patient will be admitted in guarded condition.  We did give her Tylenol, IV fluids, as well as magnesium in the emergency department Note from 10/6/2021: CHIEF COMPLAINT: Asthenia Assessment/Plan  ASSESSMENT / PLAN: Principal Problem:  Asthenia Active Problems:   COVID-19  Asthenia possibly secondary to COVID/UTI COVID-19 positive Pyuria/Urinary tract infection COVID-19 positive but chest x-ray negative  No hypoxia. Hold on remdesivir and Decadron E.coli in urine Cont rocephin for 3 days. PTOT consult Episode of syncope - ekg and trops are ok - CT angio thorax done, negative - CT head is negative - echo is normal Care management note on 10/5/2021: Plan/Reassessment: Plan Discharge Coordination/Progress: Initial Assessment done with son by phone; pt reported with Hullucinations; hx of Dementia. Pt will be out of covid isolation (day 11) by 10/11/21.  Will plan completion of 77/78 and continue to find accepting SAR.
Severe chills, headache, and body aches starting approximately 5.5 hours post-vaccination. Treated with acetaminophen 1g PO. Fatigue, headache, and dizziness beginning the following morning and persisting until approximately 9pm on 3/4/21. Treatment with acetaminophen every 6 hours as needed. After 9pm on 3/4/21, complete resolution of symptoms.
Dose 1: Extreme anxiety and feeling of uneasiness, nausea, indegestion. pressure in chest/lungs. Subsided some but remained until second does. (used DM, anti inflamatories and rest)  Dose 2: All symptoms from dose 1 but more intense and accute. Add tingling in limbs, more intense indegestion w.o eating, upper extremity pain/ache and headache. Your fill in form is not working and does not allow you to fill in all fields. My Hospital where I was admitted I spent two full days being monitored for heart attack (negative and extremely high BP and heart rate) About 50 points over normal.
Pain and generalized swelling to  left arm for 3 days post injection.  One day after injection fatigue and myalgia, Tylenol taken twice that day. Day 8 post injection a hot and painful red circle at injection site, approximately size of a quarter.  Day 9 circle is size of half dollar and still hot and painful.
Initial report received from a healthcare professional on 17 October 2014. A 38-year-old female patient, whose medical history was unknown, received an intramuscular right deltoid injection of ADACEL (lot number not reported) on 15 October 2014. One day post-vaccination, on 16 October 2014, the patient developed redness, pain, and heat at the injection site. She was sent for an ultrasound and diagnosed with cellulitis. The event subsequently resolved on an unspecified date. Documents held by sender: None.
slept for 6 hrs complexion pale & grey, irritable for short time p/waking;
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA ACUTE PULMONARY EMBOLISM CHRONIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY
The Covid 5-11y was pulled and accidentally reconstituted with normal saline 1.8ml and administered 0.3ml. After consulting with CDC and Pfizer Inc, the recommendation was to re-administer the adult dose of Pfizer as soon as possible. The patients came back in and received the correct dose.